ArticleAdvances in therapy2026

Summary of Research: Dupilumab Safety for Treating Infants to Adults with Moderate-to-Severe Atopic Dermatitis.

Richard G Langley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.